Richard N Channick

8PUBLICATIONS
64CO-AUTHORS
Respiratory diseasesClinical pharmacology and therapeuticsMajor global burdens of diseaseBioinorganic chemistryCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 08, 2026
Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension.

|Nov 03, 2025
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial.

Robert A Lookstein, Stavros V Konstantinides, Ido Weinberg

|Aug 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.

Olivier Sitbon, Sandeep Sahay, Pilar Escribano Subías

|Aug 29, 2024
Pulmonary hypertension associated with lung diseases.

Oksana A Shlobin, Yochai Adir, Joan A Barbera

|Mar 19, 2024
Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning.

Eileen M Harder, Fereidoun Abtin, Pietro Nardelli

|Mar 07, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.

Richard Channick, Kelly M Chin, Vallerie V McLaughlin

Pageof 2

Frequent Collaborators

3 joint publications

Hossein-Ardeschir Ghofrani

3 joint publications

Vallerie V McLaughlin

3 joint publications

Kelly M Chin

3 joint publications

Raymond L Benza